Boyer David W. bought NBIX
February 13, 2024 · Form 4 insider transaction
Boyer David W. bought 6,165 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,165
Price
$0.00
Total value
N/A
InsiderBoyer David W.
Role—
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateFebruary 13, 2024
Filing dateFebruary 15, 2024
Shares owned after6,165
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.; The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2025, February 13, 2026, February 13, 2027, and February 13, 2028.